PNV OB DHA (doconexent 250 mg) Dailymed
IMPRINT: P116
SHAPE: capsule
COLOR: purple
Go PRO for all pill images
Description:
PharmaPure Rx PNV OB + DHA is a prescription prenatal/postnatal multivitamin/mineral caplet and a softgel of an essential fatty acid. The prenatal vitamin is a light purple, capsule-shaped multivitamin/mineral caplet. The caplet is imprinted with the code "P-116" on one side and is blank on the other side. The essential fatty acid DHA softgel is clear and contains a pale yellow semi-solid mixture.
Each PNV OB+DHA caplet contains:
Vitamin C (Ascorbic acid)Â 120 mg Calcium (Calcium citrate) 125 mg Iron (Carbonyl iron, Ferrous gluconate) 27 mg Vitamin D3 (Cholecalciferol) 400 IU Vitamin E (dl-alpha tocopheryl acetate) 30 IU Vitamin B1 (Thiamine HCl) 3 mg Vitamin B2 (Riboflavin) 3.4 mg Vitamin B3 (Niacinamide) 20 mg Vitamin B6 (Pyridoxine HCl) 20 mg Folic Acid 1 mg Iodine (Potassium iodide) 150 mcg Zinc (Zinc oxide) 25 mg Copper (Cupric oxide) 2 mg Docusate Sodium 50 mg
Other ingredients in DHA caplet: Croscarmellose Sodium, Crospovidone, FD and C Blue #2 Aluminum Lake, Gelatin, Hydrogenated Soybean Oil, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polydextrose, Polyethylene Glycol, Polysorbate 80, Povidone, Red Iron Oxide, Silicon Dioxide, Starch, Stearic Acid, Sucrose, Titanium Dioxide, Triacetin.
Each PNV OB+DHA softgel contains:
250 mg Docosahexaenoic Acid (DHA)
Supplement Facts Serving Size: 1 Softgel  %Daily Value Docosahexaenoic Acid (DHA)     250 mg* *Daily Value not established.
DHA is contained in the oil derived from fish (tuna). Other ingredients in DHA softgel:Gelatin, Water, Glycerin, Polysorbate 80.May contain Vanillin. Also contains Eicosapentaenoic Acid (EPA) and other omega-3 fatty acids. Cloudiness of the softgel is a characteristic of natural fish oil. Contains Soy. Docusate sodium is a gentle and effective stool softener that protects against the discomfort of constipation. Contains NO artificial flavors or preservatives, yeast, wheat, gluten, nuts or milk-based by-products. PNV OB+DHA supplies important prenatal vitamins, minerals and nutrients to supplement the nutritional needs of women, before, during and after pregnancy. Deficiencies of these nutrients are common during pregnancy and lactation and should be prescribed by a physician prior to conception. PNV OB+DHA caplet is manufactured in a drug registered cGMP (current good manufacturing practice) facility and meets or exceeds USP standards for potency, purity and dissolution. PNV OB+DHA softgel complies with the most stringent worldwide standards for fish oil and is manufactured in a NSF-Certified cGMP Facility.
Indications And Usage:
PNV OB+DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
Dosage And Administration:
Before, during and after pregnancy, one caplet and one softgel taken by mouth daily, or as prescribed by a physician. The caplet and softgel may be taken together or at different times of the day.
Contraindications:
PNV OB+DHA is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Warning:
Accidental overdose of Iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.
Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and reduced clotting ratio (INR). Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions:
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestationsÂprogress.
Exercise caution to ensure that the prescribed dosage of DHA doses not exceed 1 gram (1,000 mg) per day.
NOTICE: Contact with moisture can discolor or erode the caplet.
Adverse Reactions:
Allergic sensitization has been reported following both oral and parenteral administration of folic acid. Caution should be exercised with patients with known allergies to fish or fish by-products. Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at 1-800-FDA-1088.
Use In Specific Populations:
PNV OB+DHA is not indicated for pediatric or geriatric use.
How Supplied:
PNV OB+DH A (NDC 59088-115-60) is a 30-day regimen supplied as six child-resistant buler cards each containing 5 light purple PNV OB+DHA prenatal capsule-shaped caplets NDC:59088-116-54 imprinted "P-116" and 5 pale yellow DHA softgels NDC: 59088-117-54 each.
Store at temperature 20°-25°C (68°-77°F).[See USP Controlled Room Temperature]. Keep in a cool, dry place.
Carton
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
